Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 26.37 Million USD | 21.92% |
| 2022 | 21.63 Million USD | -19.52% |
| 2021 | 26.88 Million USD | 961.39% |
| 2020 | 2.53 Million USD | -0.15% |
| 2019 | 2.53 Million USD | 18.3% |
| 2018 | 2.14 Million USD | 5.36% |
| 2017 | 2.03 Million USD | -0.91% |
| 2016 | 2.05 Million USD | 12.21% |
| 2015 | 1.83 Million USD | 9.23% |
| 2014 | 1.67 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 22.82 Million USD | -13.46% |
| 2024 Q3 | 22.99 Million USD | -7.23% |
| 2024 Q2 | 24.78 Million USD | 8.59% |
| 2023 FY | 26.37 Million USD | 21.92% |
| 2023 Q3 | 22.82 Million USD | -8.41% |
| 2023 Q1 | 23.67 Million USD | 9.42% |
| 2023 Q4 | 26.37 Million USD | 15.59% |
| 2023 Q2 | 24.91 Million USD | 5.24% |
| 2022 Q1 | 27.71 Million USD | 3.09% |
| 2022 Q4 | 21.63 Million USD | -16.95% |
| 2022 FY | 21.63 Million USD | -19.52% |
| 2022 Q3 | 26.05 Million USD | -4.33% |
| 2022 Q2 | 27.22 Million USD | -1.76% |
| 2021 Q3 | 7.31 Million USD | 6.49% |
| 2021 Q4 | 26.88 Million USD | 267.68% |
| 2021 Q1 | 6.95 Million USD | 174.7% |
| 2021 Q2 | 6.86 Million USD | -1.31% |
| 2021 FY | 26.88 Million USD | 961.39% |
| 2020 FY | 2.53 Million USD | -0.15% |
| 2020 Q4 | 2.53 Million USD | 5.62% |
| 2020 Q1 | 2.66 Million USD | 5.14% |
| 2020 Q2 | 2.5 Million USD | -6.0% |
| 2020 Q3 | 2.39 Million USD | -4.35% |
| 2019 Q3 | 2.59 Million USD | 11.13% |
| 2019 Q4 | 2.53 Million USD | -2.13% |
| 2019 Q1 | 2.45 Million USD | 14.66% |
| 2019 Q2 | 2.33 Million USD | -5.15% |
| 2019 FY | 2.53 Million USD | 18.3% |
| 2018 Q1 | 2.24 Million USD | 10.28% |
| 2018 Q2 | 2.06 Million USD | -7.89% |
| 2018 Q3 | 2.3 Million USD | 11.45% |
| 2018 Q4 | 2.14 Million USD | -6.93% |
| 2018 FY | 2.14 Million USD | 5.36% |
| 2017 Q4 | 2.03 Million USD | -5.83% |
| 2017 FY | 2.03 Million USD | -0.91% |
| 2017 Q3 | 2.16 Million USD | 2.04% |
| 2017 Q2 | 2.11 Million USD | -1.15% |
| 2017 Q1 | 2.14 Million USD | 4.32% |
| 2016 Q4 | 2.05 Million USD | -2.83% |
| 2016 Q2 | 2.1 Million USD | 11.94% |
| 2016 Q3 | 2.11 Million USD | 0.26% |
| 2016 Q1 | 1.88 Million USD | 2.89% |
| 2016 FY | 2.05 Million USD | 12.21% |
| 2015 Q2 | 1.81 Million USD | 0.46% |
| 2015 FY | 1.83 Million USD | 9.23% |
| 2015 Q3 | 1.62 Million USD | -10.51% |
| 2015 Q4 | 1.83 Million USD | 12.9% |
| 2015 Q1 | 1.8 Million USD | 7.62% |
| 2014 Q3 | 18.22 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 1.67 Million USD | 9093.95% |
| 2014 FY | 1.67 Million USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 2.42 Million USD | -985.804% |
| Talis Biomedical Corporation | 29.22 Million USD | 9.741% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -393.774% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 48.536% |
| Bioventus Inc. | 589.79 Million USD | 95.528% |
| Cerus Corporation | 144.3 Million USD | 81.721% |
| CVRx, Inc. | 39.28 Million USD | 32.851% |
| electroCore, Inc. | 8.94 Million USD | -194.885% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -120.583% |
| OrthoPediatrics Corp. | 72.56 Million USD | 63.648% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 10.83% |
| Spectral AI, Inc. | 12.4 Million USD | -112.704% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -728.972% |
| BrainsWay Ltd. | 15.31 Million USD | -72.244% |
| Envoy Medical, Inc. | 9.4 Million USD | -180.551% |
| MaxCyte, Inc. | 36.1 Million USD | 26.946% |
| NanoVibronix, Inc. | 2.68 Million USD | -882.034% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -14.02% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6102.354% |
| Orthofix Medical Inc. | 326.58 Million USD | 91.923% |
| Inogen, Inc. | 121.38 Million USD | 78.269% |
| IceCure Medical Ltd | 4.24 Million USD | -521.084% |
| PAVmed Inc | 57.13 Million USD | 53.835% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -107.852% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -3.591% |
| RxSight, Inc. | 22.18 Million USD | -18.882% |
| Sight Sciences, Inc. | 46.43 Million USD | 43.196% |
| SI-BONE, Inc. | 61.05 Million USD | 56.794% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1327.42% |
| TELA Bio, Inc. | 59.16 Million USD | 55.419% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 48.943% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 76.856% |
| Venus Concept Inc. | 107.1 Million USD | 75.372% |
| Acutus Medical, Inc. | 54.83 Million USD | 51.9% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -155.62% |
| LivaNova PLC | 1.15 Billion USD | 97.71% |
| 908 Devices Inc. | 37.49 Million USD | 29.641% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 96.25% |
| NeuroPace, Inc. | 86.99 Million USD | 69.68% |
| LENSAR, Inc. | 22.4 Million USD | -17.709% |
| Apyx Medical Corporation | 52.31 Million USD | 49.582% |
| Cutera, Inc. | 518.12 Million USD | 94.909% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 10.061% |
| BioSig Technologies, Inc. | 4.68 Million USD | -463.019% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 54.808% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -22.754% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.798% |
| Axonics, Inc. | 82.35 Million USD | 67.973% |
| Outset Medical, Inc. | 190.91 Million USD | 86.184% |
| IRIDEX Corporation | 24.91 Million USD | -5.874% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 78.722% |
| IRadimed Corporation | 20.73 Million USD | -27.206% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1475.713% |
| INVO Bioscience, Inc. | 19.99 Million USD | -31.92% |
| Telesis Bio, Inc. | 40.87 Million USD | 35.465% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 35.334% |
| Varex Imaging Corporation | 668.6 Million USD | 96.055% |
| Quipt Home Medical Corp. | 136.29 Million USD | 80.647% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -638.45% |
| Pulmonx Corporation | 60.63 Million USD | 56.499% |
| Dynatronics Corporation | 11.78 Million USD | -123.915% |
| Modular Medical, Inc. | 2.27 Million USD | -1060.978% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -549.051% |
| Semler Scientific, Inc. | 6.27 Million USD | -320.693% |
| InMode Ltd. | 75.91 Million USD | 65.254% |
| Bruker Corporation | 2.83 Billion USD | 99.07% |
| Cytosorbents Corporation | 29.98 Million USD | 12.033% |
| DexCom, Inc. | 4.19 Billion USD | 99.371% |
| Align Technology, Inc. | 2.45 Billion USD | 98.925% |
| Viveve Medical, Inc. | 10.84 Million USD | -143.177% |
| ZimVie Inc. | 795.85 Million USD | 96.686% |
| Movano Inc. | 5.97 Million USD | -341.685% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 74.784% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6102.354% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -120.583% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 95.872% |
| Profound Medical Corp. | 12.66 Million USD | -108.256% |
| Insulet Corporation | 1.85 Billion USD | 98.578% |
| enVVeno Medical Corporation | 2.43 Million USD | -983.262% |
| Surmodics, Inc. | 65.82 Million USD | 59.927% |
| iCAD, Inc. | 8 Million USD | -229.677% |
| Nuwellis, Inc. | 6.78 Million USD | -289.048% |
| Biotricity, Inc. | 35.91 Million USD | 26.565% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 88.174% |
| Aethlon Medical, Inc. | 2.47 Million USD | -963.756% |
| InspireMD, Inc. | 8.14 Million USD | -223.968% |
| PAVmed Inc. | 57.13 Million USD | 53.835% |
| BIOLASE, Inc. | 35.34 Million USD | 25.378% |
| Beyond Air, Inc. | 29.77 Million USD | 11.411% |
| FONAR Corporation | 57.45 Million USD | 54.092% |
| AxoGen, Inc. | 101.16 Million USD | 73.926% |
| Vivani Medical, Inc. | 25.03 Million USD | -5.358% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 69.956% |
| Inari Medical, Inc. | 209.32 Million USD | 87.399% |
| UFP Technologies, Inc. | 118.04 Million USD | 77.655% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1106.757% |
| Tenon Medical, Inc. | 5.56 Million USD | -373.818% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1382.711% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -49.582% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.163% |
| Sintx Technologies, Inc. | 6.59 Million USD | -300.082% |
| Quanterix Corporation | 78.08 Million USD | 66.219% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -638.45% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -439.968% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.475% |
| TransMedics Group, Inc. | 568.84 Million USD | 95.363% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -58.119% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1878.618% |
| Hyperfine, Inc. | 9.8 Million USD | -169.157% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 89.459% |
| Biomerica, Inc. | 2.66 Million USD | -890.516% |
| Bone Biologics Corporation | 831.4 Thousand USD | -3072.645% |
| AVITA Medical, Inc. | 19.86 Million USD | -32.781% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1236.457% |
| Silk Road Medical, Inc | 114.15 Million USD | 76.894% |